Enuresis nocturna and sleep quality
Enuresis nocturna is a common problem. Numerous etiologic factors have been investigated, and various theories have been proposed. The objectives of our study were to establish the differences in the sleep quality of nocturnal enuretic patients from that of healthy voluntary subjects, and the change...
Gespeichert in:
| Veröffentlicht in: | Pediatric nephrology (Berlin, West) West), 2008-08, Vol.23 (8), p.1293-1296 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1296 |
|---|---|
| container_issue | 8 |
| container_start_page | 1293 |
| container_title | Pediatric nephrology (Berlin, West) |
| container_volume | 23 |
| creator | Gozmen, Salih Keskin, Sukran Akil, Ipek |
| description | Enuresis nocturna is a common problem. Numerous etiologic factors have been investigated, and various theories have been proposed. The objectives of our study were to establish the differences in the sleep quality of nocturnal enuretic patients from that of healthy voluntary subjects, and the changes after treatment with desmopressin acetate (DDAVP), among primary school children. The study comprised 19 children with primary nocturnal enuresis and 32 healthy children in the control group. Subjective assessment of sleep was determined with the Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI scores for each patient and control subject were determined before the study was started and after a month time interval. The sleep quality of the nocturnal enuretic children was poor. We found lower scores after a month’s treatment with DDAVP, and significant differences in two dimensions in the patient group: ‘subjective sleep quality’ and ‘sleep disturbances’. When we asked the patients’ group what caused the sleep disturbance, they replied ‘the fear or the anxiety of bedwetting during sleep’. This anxiety or fear seemed to be a factor that probably affected their sleep quality. So, active treatment (medical or behavioral) should be started as soon as the child is ready to receive it or when the enuretic child wants to be dry when asleep. |
| doi_str_mv | 10.1007/s00467-008-0817-y |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69261420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A385406851</galeid><sourcerecordid>A385406851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-2059e478a50f78bf3c89d56cb5dc34a30611776fec1bcfdbf766e30070765ee43</originalsourceid><addsrcrecordid>eNp1kU1r3DAQhkVpaLZpf0AvZWkhN6Uj69PHEJK2EOglhdyELI82Dlp5I9mH_ffV4oWkJZUOAul5hxk9hHxicMEA9LcCIJSmAIaCYZru35AVE7yhrDX3b8kKWs4oCHZ_St6X8ggVlEa9I6fMSFDCtCvy9TrNGctQ1mn005yTW7vUr0tE3K2fZheHaf-BnAQXC348nmfk98313dUPevvr-8-ry1vqhdYTbUC2KLRxEoI2XeDetL1UvpO958JxUIxprQJ61vnQd0ErhbzOAVpJRMHPyPlSd5fHpxnLZLdD8RijSzjOxaq2UUw0UMEv_4CP46H1WGxTlzZcqArRBdq4iHZIYZyy8xtMmF0cE4ahXl9yIwUoI1nlL17h6-5xO_hXA-cvAg_o4vRQxjhPw5jK3yBbQJ_HUjIGu8vD1uW9ZWAPIu0i0lY_9iDS7mvm83HEudti_5w4mqtAswClPqUN5uc_-H_VP1xspbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222278346</pqid></control><display><type>article</type><title>Enuresis nocturna and sleep quality</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Gozmen, Salih ; Keskin, Sukran ; Akil, Ipek</creator><creatorcontrib>Gozmen, Salih ; Keskin, Sukran ; Akil, Ipek</creatorcontrib><description>Enuresis nocturna is a common problem. Numerous etiologic factors have been investigated, and various theories have been proposed. The objectives of our study were to establish the differences in the sleep quality of nocturnal enuretic patients from that of healthy voluntary subjects, and the changes after treatment with desmopressin acetate (DDAVP), among primary school children. The study comprised 19 children with primary nocturnal enuresis and 32 healthy children in the control group. Subjective assessment of sleep was determined with the Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI scores for each patient and control subject were determined before the study was started and after a month time interval. The sleep quality of the nocturnal enuretic children was poor. We found lower scores after a month’s treatment with DDAVP, and significant differences in two dimensions in the patient group: ‘subjective sleep quality’ and ‘sleep disturbances’. When we asked the patients’ group what caused the sleep disturbance, they replied ‘the fear or the anxiety of bedwetting during sleep’. This anxiety or fear seemed to be a factor that probably affected their sleep quality. So, active treatment (medical or behavioral) should be started as soon as the child is ready to receive it or when the enuretic child wants to be dry when asleep.</description><identifier>ISSN: 0931-041X</identifier><identifier>EISSN: 1432-198X</identifier><identifier>DOI: 10.1007/s00467-008-0817-y</identifier><identifier>PMID: 18506489</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antidiuretic Agents - administration & dosage ; Anxiety - prevention & control ; Child ; Deamino Arginine Vasopressin - administration & dosage ; Fear ; Female ; Humans ; Male ; Medicine & Public Health ; Nephrology ; Nocturnal Enuresis - drug therapy ; Nocturnal Enuresis - etiology ; Original Article ; Pediatrics ; Sleep ; Sleep Arousal Disorders - complications ; Sleep Arousal Disorders - psychology ; Surveys and Questionnaires ; Treatment Outcome ; Urology</subject><ispartof>Pediatric nephrology (Berlin, West), 2008-08, Vol.23 (8), p.1293-1296</ispartof><rights>IPNA 2008</rights><rights>COPYRIGHT 2008 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-2059e478a50f78bf3c89d56cb5dc34a30611776fec1bcfdbf766e30070765ee43</citedby><cites>FETCH-LOGICAL-c477t-2059e478a50f78bf3c89d56cb5dc34a30611776fec1bcfdbf766e30070765ee43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00467-008-0817-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00467-008-0817-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18506489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gozmen, Salih</creatorcontrib><creatorcontrib>Keskin, Sukran</creatorcontrib><creatorcontrib>Akil, Ipek</creatorcontrib><title>Enuresis nocturna and sleep quality</title><title>Pediatric nephrology (Berlin, West)</title><addtitle>Pediatr Nephrol</addtitle><addtitle>Pediatr Nephrol</addtitle><description>Enuresis nocturna is a common problem. Numerous etiologic factors have been investigated, and various theories have been proposed. The objectives of our study were to establish the differences in the sleep quality of nocturnal enuretic patients from that of healthy voluntary subjects, and the changes after treatment with desmopressin acetate (DDAVP), among primary school children. The study comprised 19 children with primary nocturnal enuresis and 32 healthy children in the control group. Subjective assessment of sleep was determined with the Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI scores for each patient and control subject were determined before the study was started and after a month time interval. The sleep quality of the nocturnal enuretic children was poor. We found lower scores after a month’s treatment with DDAVP, and significant differences in two dimensions in the patient group: ‘subjective sleep quality’ and ‘sleep disturbances’. When we asked the patients’ group what caused the sleep disturbance, they replied ‘the fear or the anxiety of bedwetting during sleep’. This anxiety or fear seemed to be a factor that probably affected their sleep quality. So, active treatment (medical or behavioral) should be started as soon as the child is ready to receive it or when the enuretic child wants to be dry when asleep.</description><subject>Antidiuretic Agents - administration & dosage</subject><subject>Anxiety - prevention & control</subject><subject>Child</subject><subject>Deamino Arginine Vasopressin - administration & dosage</subject><subject>Fear</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine & Public Health</subject><subject>Nephrology</subject><subject>Nocturnal Enuresis - drug therapy</subject><subject>Nocturnal Enuresis - etiology</subject><subject>Original Article</subject><subject>Pediatrics</subject><subject>Sleep</subject><subject>Sleep Arousal Disorders - complications</subject><subject>Sleep Arousal Disorders - psychology</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Urology</subject><issn>0931-041X</issn><issn>1432-198X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU1r3DAQhkVpaLZpf0AvZWkhN6Uj69PHEJK2EOglhdyELI82Dlp5I9mH_ffV4oWkJZUOAul5hxk9hHxicMEA9LcCIJSmAIaCYZru35AVE7yhrDX3b8kKWs4oCHZ_St6X8ggVlEa9I6fMSFDCtCvy9TrNGctQ1mn005yTW7vUr0tE3K2fZheHaf-BnAQXC348nmfk98313dUPevvr-8-ry1vqhdYTbUC2KLRxEoI2XeDetL1UvpO958JxUIxprQJ61vnQd0ErhbzOAVpJRMHPyPlSd5fHpxnLZLdD8RijSzjOxaq2UUw0UMEv_4CP46H1WGxTlzZcqArRBdq4iHZIYZyy8xtMmF0cE4ahXl9yIwUoI1nlL17h6-5xO_hXA-cvAg_o4vRQxjhPw5jK3yBbQJ_HUjIGu8vD1uW9ZWAPIu0i0lY_9iDS7mvm83HEudti_5w4mqtAswClPqUN5uc_-H_VP1xspbg</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Gozmen, Salih</creator><creator>Keskin, Sukran</creator><creator>Akil, Ipek</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20080801</creationdate><title>Enuresis nocturna and sleep quality</title><author>Gozmen, Salih ; Keskin, Sukran ; Akil, Ipek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-2059e478a50f78bf3c89d56cb5dc34a30611776fec1bcfdbf766e30070765ee43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antidiuretic Agents - administration & dosage</topic><topic>Anxiety - prevention & control</topic><topic>Child</topic><topic>Deamino Arginine Vasopressin - administration & dosage</topic><topic>Fear</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine & Public Health</topic><topic>Nephrology</topic><topic>Nocturnal Enuresis - drug therapy</topic><topic>Nocturnal Enuresis - etiology</topic><topic>Original Article</topic><topic>Pediatrics</topic><topic>Sleep</topic><topic>Sleep Arousal Disorders - complications</topic><topic>Sleep Arousal Disorders - psychology</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gozmen, Salih</creatorcontrib><creatorcontrib>Keskin, Sukran</creatorcontrib><creatorcontrib>Akil, Ipek</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric nephrology (Berlin, West)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gozmen, Salih</au><au>Keskin, Sukran</au><au>Akil, Ipek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enuresis nocturna and sleep quality</atitle><jtitle>Pediatric nephrology (Berlin, West)</jtitle><stitle>Pediatr Nephrol</stitle><addtitle>Pediatr Nephrol</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>23</volume><issue>8</issue><spage>1293</spage><epage>1296</epage><pages>1293-1296</pages><issn>0931-041X</issn><eissn>1432-198X</eissn><abstract>Enuresis nocturna is a common problem. Numerous etiologic factors have been investigated, and various theories have been proposed. The objectives of our study were to establish the differences in the sleep quality of nocturnal enuretic patients from that of healthy voluntary subjects, and the changes after treatment with desmopressin acetate (DDAVP), among primary school children. The study comprised 19 children with primary nocturnal enuresis and 32 healthy children in the control group. Subjective assessment of sleep was determined with the Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI scores for each patient and control subject were determined before the study was started and after a month time interval. The sleep quality of the nocturnal enuretic children was poor. We found lower scores after a month’s treatment with DDAVP, and significant differences in two dimensions in the patient group: ‘subjective sleep quality’ and ‘sleep disturbances’. When we asked the patients’ group what caused the sleep disturbance, they replied ‘the fear or the anxiety of bedwetting during sleep’. This anxiety or fear seemed to be a factor that probably affected their sleep quality. So, active treatment (medical or behavioral) should be started as soon as the child is ready to receive it or when the enuretic child wants to be dry when asleep.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>18506489</pmid><doi>10.1007/s00467-008-0817-y</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0931-041X |
| ispartof | Pediatric nephrology (Berlin, West), 2008-08, Vol.23 (8), p.1293-1296 |
| issn | 0931-041X 1432-198X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69261420 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Antidiuretic Agents - administration & dosage Anxiety - prevention & control Child Deamino Arginine Vasopressin - administration & dosage Fear Female Humans Male Medicine & Public Health Nephrology Nocturnal Enuresis - drug therapy Nocturnal Enuresis - etiology Original Article Pediatrics Sleep Sleep Arousal Disorders - complications Sleep Arousal Disorders - psychology Surveys and Questionnaires Treatment Outcome Urology |
| title | Enuresis nocturna and sleep quality |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A54%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enuresis%20nocturna%20and%20sleep%20quality&rft.jtitle=Pediatric%20nephrology%20(Berlin,%20West)&rft.au=Gozmen,%20Salih&rft.date=2008-08-01&rft.volume=23&rft.issue=8&rft.spage=1293&rft.epage=1296&rft.pages=1293-1296&rft.issn=0931-041X&rft.eissn=1432-198X&rft_id=info:doi/10.1007/s00467-008-0817-y&rft_dat=%3Cgale_proqu%3EA385406851%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222278346&rft_id=info:pmid/18506489&rft_galeid=A385406851&rfr_iscdi=true |